SCHEMBL14025972

SCHEMBL14025972

COc1ccc(C2CC(=O)N(c3ccccc3)C2)cc1OC1CCCC1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 16/20 0.78
PDE4A P27815 15/20 0.78
PDE4C Q08493 11/20 0.78
PDE4D Q08499 11/20 0.78
CYP3A4 P08684 2/20 0.57
VEGFA P15692 1/20 0.57
ALDH1A1 P00352 1/20 0.57
LMNA P02545 1/20 0.57
CYP1A2 P05177 1/20 0.57
MAPT P10636 1/20 0.57
CYP2C9 P11712 1/20 0.57
ALOX15 P16050 1/20 0.57
CREBBP Q92793 1/20 0.57
KDM4E B2RXH2 1/20 0.57
PDE5A O76074 1/20 0.57
TNF P01375 1/20 0.57
MAPK1 P28482 1/20 0.57
BLM P54132 1/20 0.57
PDE1A P54750 1/20 0.57
PDE1B Q01064 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13677645 1.00 PDE4B (0.78) PDE4BPDE4APDE4CPDE4DCYP3A4
SCHEMBL13922786 0.91 PDE4A (0.72) PDE4BPDE4APDE4CPDE4DCYP3A4
SCHEMBL7064476 0.91 PDE4A (0.66) PDE4BPDE4APDE4CPDE4DCYP3A4
SCHEMBL13922782 0.90 PDE4A (0.71) PDE4BPDE4APDE4CPDE4DCYP3A4
SCHEMBL13677745 0.89 PDE4A (0.67) PDE4BPDE4APDE4CPDE4DCYP3A4
SCHEMBL3892321 0.89 PDE4A (0.67) PDE4BPDE4APDE4CPDE4DCYP3A4
SCHEMBL13677661 0.89 PDE4A (0.67) PDE4BPDE4APDE4CPDE4DCYP3A4
SCHEMBL13922788 0.89 PDE4A (0.67) PDE4BPDE4APDE4CPDE4DCYP3A4
SCHEMBL4473494 0.89 PDE4A (0.69) PDE4BPDE4APDE4CPDE4DCYP3A4
SCHEMBL13677673 0.89 PDE4A (0.69) PDE4BPDE4APDE4CPDE4DCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255136-A1 PYRROLIDONES WITH ANTI-HIV ACTIVITY IRM LLC (BM) 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255136-A1 PYRROLIDONES WITH ANTI-HIV ACTIVITY PREP, DHPS, PDCD11 PDE4B 1650/4885PDE4A 1279/4885PDE4C 1189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.